Bad news and good news in AD, and how to reconcile them

被引：0
|
作者：
David S. Knopman
机构：
[1] Mayo Clinic,Department of Neurology
来源：
Nature Reviews Neurology | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
2018 saw the failure of several large clinical trials that were based on the premise that reduction of amyloid-β levels is an effective treatment for symptomatic Alzheimer disease. Yet, over the same time period, good news also emerged about the diagnostic value of tau PET imaging.
引用
收藏
页码：61 / 62
页数：1
相关论文
共 50 条
12345